Long-term Safety and Efficacy of Esketamine Nasal Spray Plus an Oral Antidepressant in Patients with Treatment-resistant Depression–an Asian Sub-group Analysis from the SUSTAIN-2 Study

Authors
Category Primary study
JournalClinical Psychopharmacology and Neuroscience
Year 2022
This article has no abstract
Epistemonikos ID: 4bd5cfd352239180329b3f60e78d5e5ad69c6f89
First added on: Feb 14, 2025